<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01179126</url>
  </required_header>
  <id_info>
    <org_study_id>CROSS-AMI</org_study_id>
    <nct_id>NCT01179126</nct_id>
  </id_info>
  <brief_title>Strategies of Revascularization in Patients With ST-segment Elevation Myocardial Infarction (STEMI) and Multivessel Disease</brief_title>
  <acronym>CROSS-AMI</acronym>
  <official_title>Complete Revascularization Or streSS Echo in Patients With Multivessel Disease and ST-segment Elevation Acute Myocardial Infarction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Complexo Hospitalario Universitario de A Coruña</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Complexo Hospitalario Universitario de A Coruña</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Multivessel disease has been reported to occur between 40 and 60% of patients with ST-segment
      elevation myocardial infarction (STEMI) and has been associated to a worse prognosis.
      Multivessel revascularization offers a myriad of potential advantages as enhance of the
      collateral blood flow, greater myocardial salvage, the stabilization of other lesions that
      can be potentially vulnerable, and the achievement of a complete revascularization, factor
      that is associated with a better prognosis. On the other hand, the prolongation of procedural
      duration, the hazard of contrast induced nephropathy and the peri-procedural complications
      can limit the widespread of this practice.

      To date, very few observational studies have focused in the multivessel revascularization
      with disparity of results. Whereas ones have observed an increase of adverse cardiovascular
      events and thus not recommend it, others have shown neutral results.

      Stress echocardiography has been shown to be an adequate technique for the diagnosis of
      coronary artery disease and could be an appropriate tool for selecting the lesions that need
      to be revascularized because they induce large areas of ischemia. However, this technique has
      also limitations like the high operator-dependence.

      Therefore, the investigators sought to study if the complete multivessel revascularization of
      patients with STEMI treated by means of primary percutaneous coronary intervention (PCI) has
      an impact on prognosis compared to a strategy of treating only those non-culprit lesions that
      produce large areas of ischemia in a stress test.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2010</start_date>
  <primary_completion_date type="Anticipated">September 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Combined event of cardiovascular death/re-myocardial infarction/revascularization of any vessel/admission due to heart failure</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of acute renal failure (contrast induced nephropathy)</measure>
    <time_frame>Admission</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost analysis of both strategies</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Death</measure>
    <time_frame>one year</time_frame>
    <description>cardiovascular death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>re-myocardial infarction</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>revascularization of any vessel</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>admission due to heart failure</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Myocardial Infarction</condition>
  <condition>Angioplasty, Transluminal, Percutaneous Coronary</condition>
  <condition>Echocardiography, Stress</condition>
  <arm_group>
    <arm_group_label>complete multivessel revascularization</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>stress echo guided revascularization</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>complete multivessel revascularization</intervention_name>
    <description>After a successful primary PCI these patients will undergo complete revascularization of non-culprit lesions in a staged procedure during the index admission</description>
    <arm_group_label>complete multivessel revascularization</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>stress echocardiography and revascularization if required</intervention_name>
    <description>after successful primary PCI, this group will undergo a stress echo to evaluate the significance of non-culprit lesions. If large area of ischemia is demonstrated, the artery supplying that are will be revascularized.</description>
    <arm_group_label>stress echo guided revascularization</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Typical chest pain lasting &gt;30 minutes with ST-segment elevation &gt;=1mm in &gt;=2
             contiguous ECG leads or left bundle branch block and presentation &lt; 48 hours since
             symptom onset.

          -  Patients undergoing rescue PCI

          -  Patients with effective lysis and coronary angiography in less than 24 hours

          -  Presence of other lesion &gt;=70% in a non-culprit artery.

          -  Informed consent

        Exclusion Criteria:

          -  Significant left main disease

          -  Lesions in vessels &lt; 2 mm

          -  Lesions in branches of a main epicardial coronary artery and short irrigation
             territory

          -  Previous coronary artery bypass graft (CABG)

          -  Any coronary intervention in the previous month

          -  Cardiogenic shock

          -  Anatomic features no suitable for coronary intervention

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rodrigo Estevez-Loureiro, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Interventional Cardiology. Complejo Hospitalario Universitario A Couna</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ramon Calvino-Santos, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Interventional Cardiology. Complejo Hospitalario A Couna</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nicolas Vazquez-Gonzalez, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Interventional Cardiology. Complejo Hospitalario A Couna</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jorge Salgado-Fernandez, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Interventional Cardiology. Complejo Hospitalario A Couna</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pablo Pinon-Esteban, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Interventional Cardiology. Complejo Hospitalario A Couna</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Guillermo Aldama-Lopez, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Interventional Cardiology. Complejo Hospitalario A Couna</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Xacobe Flores-Rios, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Interventional Cardiology. Complejo Hospitalario A Couna</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jesus Peteiro, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Stress Echo Unit. Complejo Hospitalario A Couna</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alberto Bouzas-Mosquera, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Stress Echo Unit. Complejo Hospitalario A Couna</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jose Angel Rodriguez-Fernandez, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Coronary Care Unit. Complejo Hospitalario A Couna</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rodrigo Estevez-Loureiro, MD</last_name>
    <phone>981 17 80 31</phone>
    <email>Rodrigo.Estevez.Loureiro@sergas.es</email>
  </overall_contact>
  <location>
    <facility>
      <name>Complejo Hospitalario Universitario A Coruna</name>
      <address>
        <city>A Coruna</city>
        <zip>15006</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rodrigo Estevez-Loureiro, MD</last_name>
      <phone>+34 981 178034</phone>
      <email>Rodrigo.Estevez.Loureiro@sergas.es</email>
    </contact>
    <investigator>
      <last_name>Rodrigo Estevez-Loureiro, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ramon Calvino-Santos, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nicolas Vazquez-Gonzalez, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pablo Pinon-Esteban, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Guillermo Aldama-Lopez, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jorge Salgado-Fernandez, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Xacobe Flores-Rios, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jesus Peteiro, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alberto Bouzas-Mosquera, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jose Angel Rodriguez-Fernandez, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 10, 2010</study_first_submitted>
  <study_first_submitted_qc>August 10, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 11, 2010</study_first_posted>
  <last_update_submitted>September 2, 2013</last_update_submitted>
  <last_update_submitted_qc>September 2, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 4, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Complexo Hospitalario Universitario de A Coruña</investigator_affiliation>
    <investigator_full_name>Rodrigo Estévez-Loureiro</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>myocardial infarction</keyword>
  <keyword>primary angioplasty</keyword>
  <keyword>multivessel disease</keyword>
  <keyword>stress echocardiography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>ST Elevation Myocardial Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

